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Cancer, in its various forms, is one of society's most dread diseases.
It has long occupied the attention of many workers in the biomedical field. Their
efforts at finding a cause, preventing or curing the disease have been generously
supported over the past several decades by both public and private funds.
In 1970 a group of knowledgeable consultants representing many different scien-
tific fields was convened at the request of the federal government, to determine
whether or not our present understanding of the abnormal biological processes
involved in cancer was sufficiently well developed to justify mounting a national
broad scale attack on the disease. The concensus of this meeting was that such an
effort was warranted.
Not everyone shared this point ofview, but a nation and a Congress still euphoric
over man's successful landing on the moon (July 20, 1969) were not to be denied and,
on December 23, 1971, the President signed into law the National Cancer Act.
Two of the mandates contained in this legislation were that the National Cancer
Institute would become the federal agency responsible for implementing the law and
that the National Cancer Institute would recognize, as soon as feasible, a number of
qualified institutions as Comprehensive Cancer Centers.
Simply stated, the "Centers" were to be places long noted for high quality cancer
research, education and patient care and committed to the concept of bringing new
information regarding cancer from the "laboratory bench" to the bedside as quickly
as prudently possible.
The Yale University School of Medicine and the Yale-New Haven Hospital, having
been engaged in cancer research and the care of cancer patients for many years,
applied for and succeeded in gaining recognition as one of the nation's then 17
Comprehensive Cancer Centers. This designation has, ofcourse, brought with it new
problems as well as opportunities.
It has required setting up a new administrative organization. The Center's activities
have crossed conventional academic boundaries, new personnel has been recruited to
strengthen certain areas where the activities were weak, community outreach pro-
grams have had to be devised and a host of other problems, some yet unseen, have
had to be faced and resolved.
However, there was a bright side to it all and it was the prospect ofobtaining funds
from NCI for new construction to accommodate the expansion in cancer activities.
One ofthe long standing requisites for procuring such funds is for the applicant to
raise a percentage of the total cost ofconstruction in so-called "matching funds." To
this end a group of dedicated leaders from within and outside the Yale-New Haven
Medical Center and Yale University succeeded in gaining the support ofthe Connec-
ticut State Assembly in this new venture in the amount of $1.2 million and with Yale
University's commitment of $1.7 million and NCI's grant of $4.2 million, the funds
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were in hand to proceed with a new and much needed cancer facility.
On October 7, 1976, a day-long symposium was held to mark the beginning ofthis
new construction and to bear witness to the unique collaborative effort between the
Yale-New Haven Medical Center, Yale University and the State of Connecticut in
this undertaking.
It also provided an opportunity to re-examine the original tenets contained in the
National Cancer Act on the occasion of its fifth anniversary.
The National Cancer Act will come before the 95th Congress for renewal during
the Fall of 1977. Hard questions can be expected from many different quarters as to
whether the public expectations have been or are being met.
The invited speakers have all been close to this issue over the past five years and
will be influential in plotting the future course of this piece of health legislation.
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